We’re entering uncharted territory if bad actors can both launch zero-days and exploit unaddressed backdoors with new efficiency. This is why teams need to unify their network structure and better forecast what they’re up against. The post Preparing Healthcare Networks For The Vulnerability Flood appeared first on MedCity News.
Bionyra Pharma’s pipeline includes two drugs that target the signaling protein TL1A, alone and as part of a combination approach to treat inflammatory disorders. The startup’s launch makes it a contender in an emerging drug class that includes late-clinical assets from Merck, Roche, and partners Sanofi and Teva Pharmaceuticals. The post Inflammation Startup Bionyra Launches…
Tired of watching its employers struggle to afford the cost of healthcare, Republican-controlled Indiana is trying a traditionally liberal tactic to control costs: setting government price controls on hospitals. Under a law enacted last year, five of Indiana’s largest nonprofit hospital systems cannot charge patients covered by job-based health plans more than an established price…
Mayo Clinic is deploying AI across its revenue cycle operations, but revenue cycle chair Todd Manion said he’s skeptical that these functions will be fully automated anytime soon. The post How Is Mayo Clinic Using AI in Its Revenue Cycle? appeared first on MedCity News.
Congressional Democrats are seeking to repeal the controversial WISeR model, but experts are unsure if their efforts will succeed. The post Is It Likely That the WISeR Model Will be Repealed? appeared first on MedCity News.
America funds the crisis. It’s time to fund the care that prevents it. The post Dying Without a Safety Net appeared first on MedCity News.
We do not need models that pretend every patient has equal or equitable access to care. We need models capable of recognizing disparities and responding to them. The post Is Bias in Clinical AI Good or Bad? It’s More Complicated Than That appeared first on MedCity News.
AI will continue changing how small molecules are discovered, but the candidates that generate the most interest in silico still have to succeed under real development conditions. The post AI Can Accelerate Discovery — Development Still Decides What Advances appeared first on MedCity News.
Today’s adjustment offers insight into what the next phase of the program is focusing on and will subsequently reward, and why this moment matters, especially for newer and regional plans. The post Medicare Advantage’s Big Decision: Reset or Retreat? appeared first on MedCity News.
Most recent settlement marks 14th enforcement action in OCR’s Risk Analysis Initiative